Literature DB >> 48151

Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.

H Verhaegen, W De Cock, J De Cree, F Verbruggen, M Verhaegen-Declercq, J Brugmans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48151     DOI: 10.1016/s0140-6736(75)92040-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.

Authors:  H Verhaegen; W De Cock; J De Cree
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.

Authors: 
Journal:  Br Med J       Date:  1975-08-23

3.  Restoration by levamisole of immune responses suppressed in tumor-bearing mice.

Authors:  M Shiraishi; K Himeno; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.

Authors:  W De Cock; J De Cree; H Verhaegen
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

5.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

6.  Effect of levamisole and azathioprine on the human mixed lymphocyte reaction (MLR).

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

7.  Whipple's disease in a female with impaired cell-mediated immunity unresponsive to co-trimoxazole and levamisole therapy.

Authors:  M R Haeney; I N Ross
Journal:  Postgrad Med J       Date:  1978-01       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.